4//SEC Filing
Truluck Joseph 4
Accession 0001213900-18-010099
CIK 0001513525other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:16 PM ET
Size
9.3 KB
Accession
0001213900-18-010099
Insider Transaction Report
Form 4
Truluck Joseph
Chief Financial Officer
Transactions
- Conversion
Common Stock
2018-07-31+5,927→ 80,555 total - Conversion
Convertible Note
2018-07-31−5,927→ 0 totalExercise: $0.44→ Common Stock (5,927 underlying) - Conversion
Warrant
2018-07-31+5,927→ 5,927 totalExercise: $6.25From: 2018-07-31Exp: 2023-07-31→ Common Stock (5,927 underlying)
Footnotes (1)
- [F1]The 5,927 shares of common stock and a warrant to purchase 5,927 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,980 at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001718091
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:16 PM ET
- Size
- 9.3 KB